Peer Review History

Original SubmissionJune 17, 2019

Attachments
Attachment
Submitted filename: Response to In-House-Review_June 17 2019.docx
Decision Letter - Conor Gilligan, Editor

PONE-D-19-16171

Learning to assist smokers through encounters with standardized patients: an innovative training for physicians in an Eastern European country

PLOS ONE

Dear Dr Movsisyan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The paper concisely presents the findings of a feasibility study. It is generally clear and readable. Please refer to my comments and those of the reviewer to make minor amendments to the paper.

Throughout – please check your reference formatting – need a space before the (citation).

Page 3 ‘one such scheme’ – it is unclear what this refers to. I suggest breaking the introduction into several paragraphs and beginning a new one at this point – introduce the concept of various programs designed to improve physicians smoking cessation skills and provide a few examples of other programs – not just the Swiss example you have adapted.

Please clarify and emphasise this as a feasibility study and note the future need to evaluate effectiveness through evaluation of practitioner behaviour.

We would appreciate receiving your revised manuscript by Sep 30 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Conor Gilligan

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Please correct your reference to "p=0.000" to "p<0.001" or as similarly appropriate, as p values cannot equal zero.

Additional Editor Comments:

The paper concisely presents the findings of a feasibility study. It is generally clear and readable. Please refer to my comments and those of the reviewer to make minor amendments to the paper.

Throughout – please check your reference formatting – need a space before the (citation).

Page 3 ‘one such scheme’ – it is unclear what this refers to. I suggest breaking the introduction into several paragraphs and beginning a new one at this point – introduce the concept of various programs designed to improve physicians smoking cessation skills and provide a few examples of other programs – not just the Swiss example you have adapted.

Please clarify and emphasise this as a feasibility study and note the future need to evaluate effectiveness through evaluation of practitioner behaviour.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The revised version of this manuscript addresses the previous issues raised. Below are some minor additional suggestions.

1) In the discussion could consider acknowledging that the design was a pre-post design for this feasibility study and given that there was no control group the effectiveness of the training program cannot be determined.

2) In the analysis section could consider rephrasing the first sentence to "Given the purpose of this study was to examine feasibility we aimed to recruit a sample size of 40 participants."

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

August 19, 2019

Dr. Conor Gilligan

Academic Editor

PLOS ONE

PONE-D-19-16171

Learning to assist smokers through encounters with standardized patients: an innovative training for physicians in an Eastern European country

Dear Dr. Gilligan,

Thank you very much for the review of our manuscript "Learning to assist smokers through encounters with standardized patients: an innovative training for physicians in an Eastern European country" and the valuable feedback.

On behalf of the authors’ team, I am pleased to submit a revised manuscript with addressed comments raised by the editorial team during the review process. Please kindly find the point-by-point description of our responses to the editors’ and reviewer’s comments.

Thank you very much for your consideration.

Sincerely,

Narine Movsisyan, MD, MPH

Senior Researcher

School of Public Health

American University of Armenia

40 Baghramyan Avenue

Yerevan 0019 Armenia

Phone: +374 60 612 592

Responses to the Editor’s comments

Editor’s comments:

1. Please check your reference formatting – need a space before the (citation).

Response: The formatting was corrected throughout the text.

2. Page 3 ‘one such scheme’ – it is unclear what this refers to. I suggest breaking the introduction into several paragraphs and beginning a new one at this point – introduce the concept of various programs designed to improve physicians smoking cessation skills and provide a few examples of other programs – not just the Swiss example you have adapted.

Response: Thank you very much for the suggestion. We started a new paragraph with more information on the smoking cessation graduate training programs available in Europe to put the Swiss program into the context.

“Many postgraduate programs for physicians’ smoking cessation training are available in Europe; however, their effectiveness in changing provider practices and patient smoking outcomes is not adequately evaluated. Most often, these courses cover brief intervention, pharmacotherapy, motivational interviewing skills and the stages of behavioural change (7). One such scheme, an innovative postgraduate training program implemented in teaching hospitals in Switzerland, was shown to improve both physician counselling skills and patient-related outcomes (3).”

3. Please clarify and emphasise this as a feasibility study and note the future need to evaluate effectiveness through evaluation of practitioner behaviour.

Response: We now clearly state that this is a feasibility study and that future studies would need to employ a more rigorous design for the effectiveness evaluation.

“No control group was used in this feasibility study with a pre-post design; therefore, the effectiveness of the training program cannot be determined.

Future studies will aim to evaluate the effectiveness of the training model in changing provider and patient related outcomes and to explore the ways to further improve physician counselling and prescribing skills to reach out to the smoker patients in restricted-resource settings.”

4. Please correct your reference to "p=0.000" to "p<0.001" or as similarly appropriate, as p values cannot equal zero.

Response: Done.

Responses to the Reviewer’s comments

Reviewer’s comments:

The revised version of this manuscript addresses the previous issues raised. Below are some minor additional suggestions.

1. In the discussion could consider acknowledging that the design was a pre-post design for this feasibility study and given that there was no control group the effectiveness of the training program cannot be determined.

Response: Thank you for your suggestion. We have added a clear statement on this important study limitation.

“No control group was used in this feasibility study with a pre-post design; therefore, the effectiveness of the training program cannot be determined”.

2. In the analysis section could consider rephrasing the first sentence to "Given the purpose of this study was to examine feasibility we aimed to recruit a sample size of 40 participants."

Response: The justification for the study sample size was re-phrased as suggested.

“Given the purpose of this study was to examine the feasibility of the intervention we aimed to recruit a sample size of 40 participants.”

Other points: A legend was added in the Figure 1 as requested.

Attachments
Attachment
Submitted filename: Response to Reviewers_August 19 2019.docx
Decision Letter - Conor Gilligan, Editor

Learning to assist smokers through encounters with standardized patients: an innovative training for physicians in an Eastern European country

PONE-D-19-16171R1

Dear Dr. Movsisyan,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Conor Gilligan

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for carefully addressing the comments raised about your paper. The paper reads well and makes an interesting and worthwhile contribution to the literature.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Conor Gilligan, Editor

PONE-D-19-16171R1

Learning to assist smokers through encounters with standardized patients: an innovative training for physicians in an Eastern European country

Dear Dr. Movsisyan:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Conor Gilligan

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .